The Wire The issue of the deaths of 70 children in the Gambia after consuming cough syrup is back in the news again. These deaths were linked to four Medicines made by an Indian manufacturer, Maiden Pharmaceuticals. A Gambian presidential task force has now recommended that the government must sue the drug manufacturer, Maiden Pharmaceuticals, and the drug importer, Atlantic Pharmaceuticals. It also wants the Government of India to be sued. This...
More »SEARCH RESULT
Total Matching Records found : 943
India's stretched health care system fails millions in rural areas battling sickle cell disease - ABC
Australian Broadcasting Corporation Poonam Gond is learning to describe her pain by numbers. Zero means no pain and 10 is agony. Poonam was at seven late last month. "I have never known zero pain," she said, sitting in the plastic chair where she spends most of her days. The 19-year-old has sickle cell disease, a genetic blood disorder. Her medicine ran out weeks ago. Poonam's social worker, Geeta Aayam, nods as she...
More »The need to make cancer drugs affordable -Biswajit Dhar and Chetali Rao
-The Hindu With the Rajya Sabha Standing Committee on Health expressing concern over the high cost of cancer treatment, the Government invoking Section 100 of the Patents Act is a way forward The subject of the spiralling costs of cancer Medicines and their implications that have frequently been highlighted the world over were dwelled on in a recent report (“Cancer Care Plan and Management”) by the Rajya Sabha’s Standing Committee on Health....
More »Is the RTI Act fulfilling its purpose? -Sonikka Loganathan
-The Hindu The Right to Information (RTI) Act was passed by Parliament in 2005, aiming to give people access to the records of the Central and State governments. It was a vital reform to help activists and individuals ensure transparency and accountability in governance. In a discussion moderated by Sonikka Loganathan, Anjali Bhardwaj and Saurav Das take stock of what’s working and the issues that appear to be weakening the law....
More »Maharashtra FDA recalls batch of anti-anaemic medicine after alleged cases of adverse reactions
-Scroll.in One persons died in Mumbai after allegedly being administered with Orofer FCM. The Maharashtra Food and Drug Administration has announced that it will recall a batch of anti-anaemic medicine Orofer FCM after noting multiple incidents of alleged adverse reaction, including the suspected death of a 55-year-old man in Mumbai in September. Orofer FCM is manufactured by Pune-based Emcure Pharmaceuticals, which supplies Medicines to 70 countries. It is administered in the form of...
More »
